Lumipodlin is a programmed cell death ligand 1 ( PD-L1 ) inhibitor. Lumipodlin is an antitumor agent that can be used in cancer-related research [1].
In Vitro, Lumipodlin is a programmed cell death ligand 1 (PD-L1) inhibitor[1].
References:
[1]. World Health Organization. Proposed INN: List 135. International Nonproprietary Names for Pharmaceutical Substances. WHO Drug Information. 2026;40(2):558-559.
In Vitro, Lumipodlin is a programmed cell death ligand 1 (PD-L1) inhibitor[1].
References:
[1]. World Health Organization. Proposed INN: List 135. International Nonproprietary Names for Pharmaceutical Substances. WHO Drug Information. 2026;40(2):558-559.
















